It’s not going to a dollar again. If big pharma were interested they would have bought it at $3 or $4 when we were consistently trading at over $1.5 for many months. They decided to run as far away as possible after the TLD presentation in May 2022.
Watch out for the massive increase in authorized share count. That request is coming in a few months.